๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A phase I-II study of dacarbazine in combination with outpatient interleukin-2 in metastatic malignant melanoma

โœ Scribed by Lawrence E. Flaherty; Bruce G. Redman; Guy G. Chabot; Silvana Martino; Steven M. Gualdoni; Lance K. Heilbrun; Manuel Valdivieso; Edward C. Bradley

Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
699 KB
Volume
65
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Interferon in combination with vinblasti
Interferon in combination with vinblastine in advanced malignant melanoma. A phase Iโ€“II study
โœ Stein Gundersen; A. Flokkmann ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 288 KB ๐Ÿ‘ 2 views

Nineteen patients with advanced malignant melanoma were treated with a combination of recombinant alfa-interferon (a-IFN) and vinblastine (VBL). The a-IFN was administered subcutaneously daily at an initial dose of 3 X lo6 IU escalating to a maximal dose of 9 X lo6 U daily for the first 10 weeks fol

Outpatient combination chemoimmunotherap
Outpatient combination chemoimmunotherapy for patients with metastatic melanoma : Results of a Phase I/II trial
โœ Mohammed Kashani-Sabet; Richard W. Sagebiel; Henry E. Collins; Alan B. Glassberg ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 75 KB ๐Ÿ‘ 2 views

## BACKGROUND. Few studies have examined the feasibility, safety, and efficacy of an outpatient biochemotherapy regimen of low dose, subcutaneously administered interleukin-2 (IL-2) for patients with metastatic (Stage IV) melanoma. ## METHODS. Nineteen patients were treated with intravenous cispl